HomeProducts › Infectious Disease › Eltromag 50mg Tablet

Eltromag 50mg Tablet

Salt Composition: ELTROMBOPAG

₹868.00₹1009.59

Inclusive of all taxes

Eltromag 50mg Tablet

Categories: Infectious Disease

Conditions: Anticoagulants

Product Introduction

Eltromag 50mg Tablet is an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It is used to treat low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP is an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells that aid in clotting and protect blood vessel walls. When platelet levels are low, it can result in severe bleeding and bruising. This tablet is also used in adults to treat low blood counts caused by severe aplastic anaemia, a serious blood disease that occurs when the bone marrow fails to produce enough new blood cells.

Eltromag 50 mg substitutes include Eltrofer, Eltrocal, Magfer, Magtron, and Feromag, which contain similar combinations of elemental magnesium and other supportive minerals.

This drug should not be used in patients with known hypersensitivity or allergic reactions to the drug or its components. Allergic reactions can range from mild to severe and may include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing.

Eltromag 50mg Tablets are contraindicated in patients with severe liver impairment or active liver disease. This drug can potentially cause hepatotoxicity, as increased liver enzymes and bilirubin levels indicate. Use in patients with severe liver disease can further worsen liver function, so caution is advised.

Your doctor will recommend that you are checked for cataracts. Your doctor should arrange regular testing if you do not have routine eye tests. You may also be checked for bleeding in or around your retina, the light-sensitive layer of cells at the back of the eye.

If you stop taking this tablet, your blood platelet count is likely to become low again within several days. The platelet count will be monitored, and your doctor will discuss appropriate precautions. A very high blood platelet count may increase the risk of blood clotting. However, blood clots can also form with normal or even low platelet counts. Your doctor will adjust your dose of this medicine to ensure that your platelet count does not become too high.

Do not take this tablet with dairy products or drinks, as the calcium in these items affects the absorption of the medicine. Use effective birth control during treatment, and if you become pregnant, you must inform your doctor.

Eltromag 50mg Tablets are not advised for children under one year with ITP. It is also not recommended for patients under 18 years with low platelet counts caused by hepatitis C or severe aplastic anaemia.

Tell your doctor if you are taking, have recently taken, or might take other medicines. This includes medicines obtained without a prescription and vitamins.

Uses

Eltromag 50 mg uses to treat, Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection. Severe aplastic anemia

How it works

Eltromag 50mg Tablets stimulate megakaryocytes (the large bone marrow cells) responsible for producing platelets. By raising the number of platelets in the blood, this drug prevents bleeding and bruising.

How to Use

It is an orally available prescription drug. Your doctor will decide the eltromag 50 mg dosage and duration of the drug based on the disease condition and other factors. Always take an Eltromag 50mg Tablet as prescribed by your doctor. Take the tablet with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.

Side Effects

Eltromag 50 mg side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Nausea Diarrhea, abdominal pain Common cold Cough Respiratory tract infection Back pain High temperature, cough Loss of appetite Hair loss Swelling in feet or hands Headache, dizziness Mouth and throat pain Joint pain

References

  1. Novartis Pharmaceuticals UK Limited, Electronic medicines compendium (EMC), [ Revised on Jan 2022] [Accessed on 22 May 2023], https://www.medicines.org.uk/emc/files/pil.508.pdf
  2. GlaxoSmithKline, US Food and Drug Administration, [ Revised on October 2008] [Accessed on 22 May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022291lbl.pdf
  3. Revolade, Annex I summary of Product Characteristics - European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/product-information/revolade-epar-product-information_en.pdf [Accessed on 22 May 2023].

Safety Advice

Pregnancy: Consult your doctor Eltromag 50mg Tablet is not recommended for pregnant patients because it may cause fetal harm. You must inform your doctor if you are pregnant, suspecting, or planning to get pregnant during the treatment.

Lungs: Consult your doctor It is unknown whether Eltromag 50mg Tablet can be prescribed for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe It is not known whether Eltromag 50mg Tablet passes into breast milk. If you are breastfeeding or planning to breastfeed, tell your doctor.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS